Robert Weinstein
Concepts (337)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glucocorticoids | 13 | 2017 | 230 | 3.400 |
Why?
| Bone and Bones | 21 | 2024 | 478 | 2.270 |
Why?
| Osteocytes | 15 | 2015 | 224 | 2.100 |
Why?
| Osteoblasts | 29 | 2024 | 462 | 1.950 |
Why?
| Osteoporosis | 10 | 2018 | 156 | 1.770 |
Why?
| Apoptosis | 21 | 2017 | 1097 | 1.640 |
Why?
| Osteonecrosis | 4 | 2017 | 34 | 1.590 |
Why?
| Osteoclasts | 20 | 2017 | 427 | 1.560 |
Why?
| Diphosphonates | 8 | 2013 | 90 | 1.510 |
Why?
| Bone Density | 25 | 2024 | 386 | 1.470 |
Why?
| Bone Density Conservation Agents | 6 | 2013 | 74 | 1.160 |
Why?
| Bone Remodeling | 11 | 2017 | 149 | 1.010 |
Why?
| Alendronate | 5 | 2011 | 23 | 0.980 |
Why?
| Osteogenesis | 11 | 2018 | 356 | 0.830 |
Why?
| Prednisolone | 5 | 2011 | 53 | 0.820 |
Why?
| Aging | 10 | 2017 | 693 | 0.690 |
Why?
| Hypophosphatemia | 1 | 2019 | 4 | 0.670 |
Why?
| Parathyroid Hormone | 7 | 2010 | 149 | 0.670 |
Why?
| Mice | 38 | 2024 | 5687 | 0.630 |
Why?
| Animals | 46 | 2024 | 13124 | 0.600 |
Why?
| Femur Head Necrosis | 1 | 2017 | 18 | 0.580 |
Why?
| Femur Head | 1 | 2017 | 25 | 0.570 |
Why?
| Alveolar Bone Loss | 2 | 2010 | 17 | 0.560 |
Why?
| Estrogen Receptor alpha | 5 | 2015 | 88 | 0.480 |
Why?
| Bone Resorption | 10 | 2014 | 302 | 0.480 |
Why?
| Dental Implantation, Endosseous | 2 | 2017 | 18 | 0.480 |
Why?
| Mice, Inbred C57BL | 18 | 2018 | 1808 | 0.450 |
Why?
| RANK Ligand | 9 | 2014 | 187 | 0.440 |
Why?
| Osteoprotegerin | 2 | 2011 | 54 | 0.390 |
Why?
| Oxidative Stress | 8 | 2013 | 772 | 0.360 |
Why?
| Femur | 8 | 2016 | 130 | 0.350 |
Why?
| Jaw, Edentulous | 1 | 2010 | 2 | 0.340 |
Why?
| Immediate Dental Implant Loading | 1 | 2010 | 7 | 0.340 |
Why?
| Dental Prosthesis, Implant-Supported | 1 | 2010 | 12 | 0.340 |
Why?
| Mandible | 1 | 2010 | 28 | 0.330 |
Why?
| Imidazoles | 1 | 2010 | 127 | 0.330 |
Why?
| Water | 1 | 2009 | 76 | 0.330 |
Why?
| Neovascularization, Physiologic | 1 | 2009 | 68 | 0.320 |
Why?
| Wnt Signaling Pathway | 4 | 2016 | 86 | 0.320 |
Why?
| Spinal Fractures | 1 | 2009 | 38 | 0.310 |
Why?
| Forkhead Transcription Factors | 4 | 2014 | 110 | 0.310 |
Why?
| Female | 34 | 2024 | 27081 | 0.300 |
Why?
| Mice, Transgenic | 11 | 2024 | 540 | 0.290 |
Why?
| Gene Deletion | 6 | 2015 | 261 | 0.270 |
Why?
| Orchiectomy | 3 | 2015 | 38 | 0.270 |
Why?
| Male | 22 | 2024 | 25907 | 0.270 |
Why?
| Cell Differentiation | 6 | 2013 | 640 | 0.260 |
Why?
| Maxillary Diseases | 1 | 2006 | 2 | 0.260 |
Why?
| Jaw | 1 | 2006 | 4 | 0.260 |
Why?
| Calcium | 6 | 2014 | 398 | 0.260 |
Why?
| Humans | 27 | 2024 | 50503 | 0.250 |
Why?
| Cells, Cultured | 10 | 2018 | 1571 | 0.240 |
Why?
| Membrane Proteins | 2 | 2024 | 332 | 0.230 |
Why?
| Blindness | 1 | 2024 | 31 | 0.230 |
Why?
| Dental Enamel Proteins | 1 | 2004 | 1 | 0.230 |
Why?
| GTP Phosphohydrolases | 1 | 2024 | 28 | 0.220 |
Why?
| Signal Transduction | 7 | 2015 | 1624 | 0.220 |
Why?
| Dexamethasone | 4 | 2011 | 432 | 0.220 |
Why?
| Radiography | 6 | 2013 | 485 | 0.220 |
Why?
| Spine | 6 | 2016 | 90 | 0.220 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2003 | 24 | 0.220 |
Why?
| Estrogen Replacement Therapy | 1 | 2003 | 41 | 0.210 |
Why?
| Middle Aged | 9 | 2020 | 12611 | 0.210 |
Why?
| Menopause | 1 | 2003 | 55 | 0.210 |
Why?
| Porosity | 3 | 2017 | 31 | 0.200 |
Why?
| Cell Line | 3 | 2011 | 988 | 0.190 |
Why?
| Double-Blind Method | 3 | 2010 | 708 | 0.190 |
Why?
| Femoral Fractures | 2 | 2013 | 40 | 0.190 |
Why?
| Wnt Proteins | 4 | 2016 | 98 | 0.190 |
Why?
| Estrogens | 4 | 2012 | 226 | 0.190 |
Why?
| Reactive Oxygen Species | 5 | 2014 | 409 | 0.180 |
Why?
| Periosteum | 2 | 2012 | 26 | 0.180 |
Why?
| Osteogenesis Imperfecta | 1 | 2020 | 37 | 0.180 |
Why?
| Adult | 6 | 2020 | 13577 | 0.170 |
Why?
| Enhancer Elements, Genetic | 2 | 2011 | 58 | 0.170 |
Why?
| Calcitriol | 1 | 2019 | 39 | 0.170 |
Why?
| Phosphates | 1 | 2019 | 46 | 0.170 |
Why?
| Fibroblast Growth Factors | 1 | 2019 | 45 | 0.160 |
Why?
| Hyperparathyroidism | 2 | 2011 | 31 | 0.160 |
Why?
| Iron | 1 | 2019 | 121 | 0.150 |
Why?
| Stem Cells | 4 | 2013 | 166 | 0.150 |
Why?
| Single-Chain Antibodies | 1 | 2018 | 21 | 0.150 |
Why?
| Epitopes | 1 | 2018 | 59 | 0.150 |
Why?
| Lumbar Vertebrae | 2 | 2013 | 102 | 0.150 |
Why?
| Immunoglobulin M | 1 | 2018 | 58 | 0.150 |
Why?
| Blotting, Western | 4 | 2016 | 578 | 0.140 |
Why?
| Biopsy | 3 | 2017 | 588 | 0.140 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2009 | 12 | 0.140 |
Why?
| Dental Implants | 1 | 2017 | 30 | 0.140 |
Why?
| Osseointegration | 1 | 2017 | 32 | 0.140 |
Why?
| Titanium | 1 | 2017 | 47 | 0.140 |
Why?
| Mice, Knockout | 6 | 2018 | 844 | 0.140 |
Why?
| Androgens | 2 | 2015 | 70 | 0.140 |
Why?
| Autophagy | 2 | 2015 | 170 | 0.130 |
Why?
| Osteopetrosis | 1 | 2015 | 3 | 0.130 |
Why?
| rac GTP-Binding Proteins | 1 | 2015 | 5 | 0.130 |
Why?
| rac1 GTP-Binding Protein | 1 | 2015 | 10 | 0.130 |
Why?
| Neuropeptides | 1 | 2015 | 37 | 0.130 |
Why?
| Apolipoproteins E | 1 | 2016 | 58 | 0.120 |
Why?
| Gene Expression Regulation | 3 | 2011 | 955 | 0.120 |
Why?
| Bone Diseases, Metabolic | 1 | 2016 | 74 | 0.120 |
Why?
| Receptors, Androgen | 1 | 2015 | 45 | 0.120 |
Why?
| Dental Prosthesis Design | 2 | 2017 | 17 | 0.120 |
Why?
| X-Ray Microtomography | 4 | 2016 | 79 | 0.120 |
Why?
| Aorta | 1 | 2016 | 163 | 0.120 |
Why?
| Diaphyses | 2 | 2013 | 3 | 0.120 |
Why?
| Aged | 5 | 2013 | 9741 | 0.120 |
Why?
| Calcium, Dietary | 1 | 2014 | 13 | 0.120 |
Why?
| Estradiol | 3 | 2013 | 221 | 0.110 |
Why?
| Catalase | 1 | 2014 | 67 | 0.110 |
Why?
| Antibodies, Monoclonal, Humanized | 2 | 2013 | 226 | 0.110 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2016 | 393 | 0.110 |
Why?
| bcl-2-Associated X Protein | 1 | 2014 | 57 | 0.110 |
Why?
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2014 | 20 | 0.110 |
Why?
| Hydrogen Peroxide | 1 | 2014 | 113 | 0.110 |
Why?
| Organ Size | 3 | 2015 | 223 | 0.110 |
Why?
| Atherosclerosis | 1 | 2016 | 217 | 0.110 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 179 | 0.100 |
Why?
| Cell Count | 4 | 2016 | 150 | 0.100 |
Why?
| Cell Proliferation | 5 | 2018 | 985 | 0.100 |
Why?
| Weight-Bearing | 1 | 2012 | 46 | 0.100 |
Why?
| Risk Factors | 3 | 2013 | 3724 | 0.100 |
Why?
| Osteoporotic Fractures | 1 | 2012 | 11 | 0.100 |
Why?
| Teriparatide | 1 | 2012 | 10 | 0.100 |
Why?
| Cell Nucleus | 1 | 2013 | 182 | 0.100 |
Why?
| Bone Demineralization, Pathologic | 1 | 2011 | 5 | 0.100 |
Why?
| Drug Monitoring | 1 | 2012 | 79 | 0.100 |
Why?
| Bone Matrix | 1 | 2011 | 16 | 0.090 |
Why?
| Lactation | 1 | 2011 | 58 | 0.090 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 20 | 0.090 |
Why?
| Transcription Factors | 4 | 2013 | 565 | 0.090 |
Why?
| Prednisone | 1 | 2011 | 101 | 0.090 |
Why?
| Prospective Studies | 2 | 2010 | 2378 | 0.090 |
Why?
| Vitamin D | 1 | 2011 | 87 | 0.090 |
Why?
| Minerals | 1 | 2010 | 29 | 0.090 |
Why?
| Advisory Committees | 1 | 2010 | 65 | 0.090 |
Why?
| Anti-Inflammatory Agents | 1 | 2011 | 163 | 0.090 |
Why?
| Dental Restoration, Temporary | 1 | 2010 | 2 | 0.090 |
Why?
| Dental Prosthesis Retention | 1 | 2010 | 5 | 0.090 |
Why?
| Bone Diseases | 1 | 2011 | 96 | 0.090 |
Why?
| Dental Restoration Failure | 1 | 2010 | 8 | 0.090 |
Why?
| Tooth Socket | 1 | 2010 | 8 | 0.090 |
Why?
| Fractures, Bone | 1 | 2011 | 109 | 0.090 |
Why?
| Dental Abutments | 1 | 2010 | 12 | 0.090 |
Why?
| Research | 1 | 2010 | 106 | 0.090 |
Why?
| Interleukin-6 | 2 | 2016 | 261 | 0.080 |
Why?
| Computer-Aided Design | 1 | 2010 | 22 | 0.080 |
Why?
| Time Factors | 4 | 2010 | 2935 | 0.080 |
Why?
| Drug Administration Schedule | 1 | 2010 | 370 | 0.080 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 57 | 0.080 |
Why?
| Societies, Medical | 1 | 2010 | 187 | 0.080 |
Why?
| Stress, Mechanical | 1 | 2009 | 92 | 0.080 |
Why?
| Acid Phosphatase | 1 | 2009 | 12 | 0.080 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2009 | 182 | 0.080 |
Why?
| Integrases | 3 | 2015 | 43 | 0.080 |
Why?
| Connexin 43 | 1 | 2008 | 25 | 0.080 |
Why?
| Education, Medical, Continuing | 1 | 2009 | 71 | 0.080 |
Why?
| Inflammation Mediators | 1 | 2009 | 111 | 0.080 |
Why?
| Receptors, Parathyroid Hormone | 1 | 2008 | 9 | 0.080 |
Why?
| Multienzyme Complexes | 2 | 2010 | 36 | 0.080 |
Why?
| Ovariectomy | 4 | 2013 | 115 | 0.080 |
Why?
| Isoenzymes | 1 | 2009 | 168 | 0.080 |
Why?
| Mitosis | 1 | 2008 | 88 | 0.080 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2008 | 24 | 0.080 |
Why?
| Patient Satisfaction | 1 | 2010 | 278 | 0.070 |
Why?
| Practice Guidelines as Topic | 1 | 2011 | 468 | 0.070 |
Why?
| Postmenopause | 1 | 2009 | 96 | 0.070 |
Why?
| Linear Models | 1 | 2009 | 279 | 0.070 |
Why?
| Administration, Oral | 1 | 2009 | 434 | 0.070 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2010 | 102 | 0.070 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 95 | 0.070 |
Why?
| Asthma | 1 | 2011 | 284 | 0.070 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 572 | 0.070 |
Why?
| Gonadal Steroid Hormones | 1 | 2007 | 41 | 0.070 |
Why?
| X Chromosome | 1 | 2006 | 12 | 0.070 |
Why?
| Treatment Outcome | 2 | 2010 | 5283 | 0.070 |
Why?
| Shc Signaling Adaptor Proteins | 3 | 2011 | 20 | 0.070 |
Why?
| Quantitative Trait Loci | 1 | 2006 | 42 | 0.070 |
Why?
| Membrane Glycoproteins | 2 | 2005 | 245 | 0.070 |
Why?
| Phosphorylation | 4 | 2010 | 525 | 0.070 |
Why?
| Models, Animal | 2 | 2017 | 227 | 0.070 |
Why?
| Osteoporosis, Postmenopausal | 1 | 2006 | 30 | 0.070 |
Why?
| Body Weight | 2 | 2010 | 517 | 0.070 |
Why?
| Carrier Proteins | 2 | 2005 | 298 | 0.070 |
Why?
| Weightlessness | 1 | 2006 | 12 | 0.070 |
Why?
| Rheumatology | 1 | 2006 | 8 | 0.060 |
Why?
| Lipoproteins, LDL | 2 | 2018 | 170 | 0.060 |
Why?
| Phenotype | 3 | 2015 | 739 | 0.060 |
Why?
| Adipocytes | 2 | 2004 | 126 | 0.060 |
Why?
| Absorptiometry, Photon | 3 | 2016 | 155 | 0.060 |
Why?
| Dose-Response Relationship, Drug | 1 | 2009 | 1372 | 0.060 |
Why?
| Diet, High-Fat | 2 | 2018 | 214 | 0.060 |
Why?
| Bone Diseases, Developmental | 1 | 2024 | 14 | 0.060 |
Why?
| Thiazolidinediones | 1 | 2004 | 82 | 0.060 |
Why?
| Neuromuscular Junction | 1 | 2024 | 10 | 0.060 |
Why?
| Periodontal Attachment Loss | 1 | 2004 | 2 | 0.060 |
Why?
| Tooth Root | 1 | 2004 | 2 | 0.060 |
Why?
| Dental Plaque Index | 1 | 2004 | 3 | 0.060 |
Why?
| Compressive Strength | 1 | 2004 | 12 | 0.060 |
Why?
| Periodontal Pocket | 1 | 2004 | 5 | 0.060 |
Why?
| Periodontal Index | 1 | 2004 | 11 | 0.060 |
Why?
| Edetic Acid | 1 | 2004 | 14 | 0.060 |
Why?
| Seminal Vesicles | 1 | 2004 | 13 | 0.060 |
Why?
| Tensile Strength | 1 | 2003 | 30 | 0.060 |
Why?
| Chelating Agents | 1 | 2004 | 28 | 0.060 |
Why?
| Arachidonate 12-Lipoxygenase | 2 | 2016 | 12 | 0.060 |
Why?
| Arachidonate 15-Lipoxygenase | 2 | 2016 | 12 | 0.060 |
Why?
| Femur Neck | 1 | 2003 | 6 | 0.060 |
Why?
| Mitochondrial Proteins | 1 | 2024 | 88 | 0.050 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 67 | 0.050 |
Why?
| Bone Regeneration | 1 | 2004 | 74 | 0.050 |
Why?
| Cell Division | 1 | 2004 | 291 | 0.050 |
Why?
| Pregnancy, Animal | 1 | 2003 | 30 | 0.050 |
Why?
| Diet, Reducing | 1 | 2003 | 37 | 0.050 |
Why?
| Mice, 129 Strain | 2 | 2013 | 37 | 0.050 |
Why?
| Surgical Flaps | 1 | 2004 | 114 | 0.050 |
Why?
| RNA, Messenger | 4 | 2010 | 1089 | 0.050 |
Why?
| Image Processing, Computer-Assisted | 1 | 2004 | 243 | 0.050 |
Why?
| Analysis of Variance | 2 | 2014 | 552 | 0.050 |
Why?
| Extracellular Matrix Proteins | 2 | 2014 | 68 | 0.050 |
Why?
| Sex Characteristics | 1 | 2003 | 198 | 0.050 |
Why?
| Neoplasm Proteins | 1 | 2003 | 320 | 0.050 |
Why?
| 5' Untranslated Regions | 1 | 2020 | 25 | 0.050 |
Why?
| Cell Cycle Proteins | 2 | 2013 | 161 | 0.040 |
Why?
| Models, Biological | 3 | 2010 | 716 | 0.040 |
Why?
| Macrophages | 2 | 2016 | 364 | 0.040 |
Why?
| Transcription, Genetic | 3 | 2010 | 361 | 0.040 |
Why?
| Child | 2 | 2024 | 6906 | 0.040 |
Why?
| Gene Knock-In Techniques | 2 | 2010 | 23 | 0.040 |
Why?
| Cell Survival | 1 | 2002 | 589 | 0.040 |
Why?
| Bone Marrow | 2 | 2013 | 363 | 0.040 |
Why?
| Proteins | 1 | 2003 | 339 | 0.040 |
Why?
| Follow-Up Studies | 1 | 2004 | 2242 | 0.040 |
Why?
| Muscle, Skeletal | 1 | 2024 | 784 | 0.040 |
Why?
| Acid Etching, Dental | 1 | 2017 | 1 | 0.040 |
Why?
| Dental Alloys | 1 | 2017 | 3 | 0.040 |
Why?
| Implants, Experimental | 1 | 2017 | 6 | 0.040 |
Why?
| Microscopy, Electron, Scanning | 1 | 2017 | 48 | 0.040 |
Why?
| Surface Properties | 1 | 2017 | 72 | 0.030 |
Why?
| Materials Testing | 1 | 2017 | 56 | 0.030 |
Why?
| Antioxidants | 2 | 2010 | 239 | 0.030 |
Why?
| Oxidation-Reduction | 1 | 2018 | 316 | 0.030 |
Why?
| Mice, Inbred BALB C | 1 | 2017 | 296 | 0.030 |
Why?
| Tibia | 1 | 2017 | 119 | 0.030 |
Why?
| Genotype | 2 | 2008 | 533 | 0.030 |
Why?
| Immunomagnetic Separation | 1 | 2016 | 7 | 0.030 |
Why?
| Swine | 1 | 2017 | 408 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2016 | 72 | 0.030 |
Why?
| Monocytes | 1 | 2016 | 127 | 0.030 |
Why?
| Cell Lineage | 1 | 2015 | 83 | 0.030 |
Why?
| Immunoblotting | 1 | 2015 | 115 | 0.030 |
Why?
| Mutation | 1 | 2020 | 1280 | 0.030 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 2 | 2005 | 33 | 0.030 |
Why?
| Hyperthyroidism | 1 | 2014 | 28 | 0.030 |
Why?
| DNA Primers | 1 | 2014 | 206 | 0.030 |
Why?
| Fractures, Stress | 1 | 2013 | 5 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 181 | 0.030 |
Why?
| Gene Knockout Techniques | 1 | 2013 | 39 | 0.030 |
Why?
| Flow Cytometry | 1 | 2016 | 474 | 0.030 |
Why?
| Adipogenesis | 1 | 2013 | 49 | 0.030 |
Why?
| Atrophy | 1 | 2013 | 37 | 0.030 |
Why?
| Microtubule-Associated Proteins | 1 | 2013 | 66 | 0.030 |
Why?
| Mice, Mutant Strains | 1 | 2012 | 69 | 0.030 |
Why?
| Homeostasis | 1 | 2014 | 204 | 0.030 |
Why?
| Uterus | 1 | 2013 | 85 | 0.030 |
Why?
| Infant | 1 | 2020 | 3628 | 0.020 |
Why?
| Histological Techniques | 1 | 2011 | 9 | 0.020 |
Why?
| Adiposity | 1 | 2013 | 137 | 0.020 |
Why?
| MAP Kinase Kinase 4 | 1 | 2011 | 29 | 0.020 |
Why?
| Inflammation | 1 | 2016 | 610 | 0.020 |
Why?
| Chondrocytes | 1 | 2011 | 40 | 0.020 |
Why?
| Young Adult | 1 | 2020 | 4102 | 0.020 |
Why?
| beta Catenin | 1 | 2011 | 97 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 156 | 0.020 |
Why?
| Health Planning Guidelines | 1 | 2010 | 14 | 0.020 |
Why?
| Solubility | 1 | 2010 | 71 | 0.020 |
Why?
| Genetic Markers | 1 | 2010 | 104 | 0.020 |
Why?
| Hip Fractures | 1 | 2010 | 47 | 0.020 |
Why?
| Smad1 Protein | 1 | 2010 | 5 | 0.020 |
Why?
| Glutathione Reductase | 1 | 2010 | 14 | 0.020 |
Why?
| Bone Morphogenetic Proteins | 1 | 2010 | 57 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 449 | 0.020 |
Why?
| Chimera | 1 | 2010 | 10 | 0.020 |
Why?
| Glycoproteins | 1 | 2010 | 116 | 0.020 |
Why?
| Transgenes | 1 | 2010 | 52 | 0.020 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2010 | 45 | 0.020 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 80 | 0.020 |
Why?
| Gene Targeting | 1 | 2010 | 30 | 0.020 |
Why?
| Organ Specificity | 1 | 2010 | 109 | 0.020 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 198 | 0.020 |
Why?
| Enzyme Activation | 1 | 2010 | 268 | 0.020 |
Why?
| Bone Marrow Cells | 1 | 2010 | 196 | 0.020 |
Why?
| Diagnostic Imaging | 1 | 2010 | 180 | 0.020 |
Why?
| Thymidine Kinase | 1 | 2008 | 18 | 0.020 |
Why?
| Ganciclovir | 1 | 2008 | 25 | 0.020 |
Why?
| Osteocalcin | 1 | 2008 | 43 | 0.020 |
Why?
| Gene Silencing | 1 | 2008 | 115 | 0.020 |
Why?
| Up-Regulation | 1 | 2010 | 446 | 0.020 |
Why?
| Collagen Type I | 1 | 2008 | 81 | 0.020 |
Why?
| Lymphoid Tissue | 1 | 2007 | 18 | 0.020 |
Why?
| Phosphoproteins | 1 | 2008 | 115 | 0.020 |
Why?
| DNA Replication | 1 | 2008 | 156 | 0.020 |
Why?
| Hormones | 1 | 2007 | 57 | 0.020 |
Why?
| Weight Gain | 1 | 2008 | 237 | 0.020 |
Why?
| Species Specificity | 1 | 2006 | 187 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2008 | 465 | 0.020 |
Why?
| Histocytochemistry | 1 | 2005 | 44 | 0.020 |
Why?
| Blotting, Northern | 1 | 2005 | 110 | 0.020 |
Why?
| Densitometry | 1 | 2004 | 11 | 0.020 |
Why?
| Mesoderm | 1 | 2004 | 26 | 0.010 |
Why?
| PPAR gamma | 1 | 2004 | 65 | 0.010 |
Why?
| Sex Factors | 1 | 2006 | 712 | 0.010 |
Why?
| Ligands | 1 | 2004 | 203 | 0.010 |
Why?
| Fatty Acids | 1 | 2004 | 144 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2006 | 475 | 0.010 |
Why?
| bcl-Associated Death Protein | 1 | 2003 | 9 | 0.010 |
Why?
| Dactinomycin | 1 | 2003 | 22 | 0.010 |
Why?
| Culture Media, Conditioned | 1 | 2003 | 47 | 0.010 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2003 | 44 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2006 | 511 | 0.010 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 33 | 0.010 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 51 | 0.010 |
Why?
| Age Factors | 1 | 2006 | 1110 | 0.010 |
Why?
| Models, Genetic | 1 | 2003 | 172 | 0.010 |
Why?
| Hypoglycemic Agents | 1 | 2004 | 173 | 0.010 |
Why?
| Rats, Long-Evans | 1 | 2003 | 26 | 0.010 |
Why?
| Iodine Radioisotopes | 1 | 2003 | 35 | 0.010 |
Why?
| HeLa Cells | 1 | 2003 | 247 | 0.010 |
Why?
| Adiponectin | 1 | 2003 | 46 | 0.010 |
Why?
| Gene Expression | 1 | 2005 | 610 | 0.010 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 116 | 0.010 |
Why?
| RNA | 1 | 2003 | 163 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 2003 | 160 | 0.010 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 128 | 0.010 |
Why?
| Kinetics | 1 | 2003 | 623 | 0.010 |
Why?
| Rats | 1 | 2003 | 3292 | 0.010 |
Why?
| Pregnancy | 1 | 2003 | 2452 | 0.010 |
Why?
|
|
Weinstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|